These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 9724903)

  • 21. Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.
    Solorio L; Olear AM; Hamilton JI; Patel RB; Beiswenger AC; Wallace JE; Zhou H; Exner AA
    Theranostics; 2012; 2(11):1064-77. PubMed ID: 23227123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
    Yoo HS; Oh JE; Lee KH; Park TG
    Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
    Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
    Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of ciprofloxacin implants in treating experimental osteomyelitis.
    Alvarez H; Castro C; Moujir L; Perera A; Delgado A; Soriano I; Evora C; Sánchez E
    J Biomed Mater Res B Appl Biomater; 2008 Apr; 85(1):93-104. PubMed ID: 17696153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implantation of vancomycin microspheres in blend with human/rabbit bone grafts to infected bone defects.
    Sayin B; Caliş S; Atilla B; Marangoz S; Hincal AA
    J Microencapsul; 2006 Aug; 23(5):553-66. PubMed ID: 16980276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co-glycolide).
    Frank A; Kumar Rath S; Boey F; Venkatraman S
    Biomaterials; 2004 Feb; 25(5):813-21. PubMed ID: 14609670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of insulin-loaded PLA/PLGA microcapsules by a novel membrane emulsification method and its release in vitro.
    Liu R; Huang SS; Wan YH; Ma GH; Su ZG
    Colloids Surf B Biointerfaces; 2006 Aug; 51(1):30-8. PubMed ID: 16814994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers.
    Son JS; Choi YA; Park EK; Kwon TY; Kim KH; Lee KB
    J Biomed Mater Res B Appl Biomater; 2013 Feb; 101(2):247-57. PubMed ID: 23143817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A drug-eluting contact lens.
    Ciolino JB; Hoare TR; Iwata NG; Behlau I; Dohlman CH; Langer R; Kohane DS
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3346-52. PubMed ID: 19136709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved small molecule drug release from in situ forming poly(lactic-co-glycolic acid) scaffolds incorporating poly(β-amino ester) and hydroxyapatite microparticles.
    Fisher PD; Palomino P; Milbrandt TA; Hilt JZ; Puleo DA
    J Biomater Sci Polym Ed; 2014; 25(11):1174-93. PubMed ID: 24903524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release behavior of poly(lactic acid-co-glycolic acid) implants containing phosphorothioate oligodeoxynucleotide.
    Yamakawa I; Ishida M; Kato T; Ando H; Asakawa N
    Biol Pharm Bull; 1997 Apr; 20(4):455-9. PubMed ID: 9145231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro release of new quinolones from biodegradable systems: a comparative study.
    Andreopoulos AG; Korakis T; Dounis E; Anastasiadis A; Tzivelekis P; Kanellakopoulou K
    J Biomater Appl; 1996 Apr; 10(4):338-47. PubMed ID: 8859405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-month ciprofloxacin implants for multibacterial bone infections.
    Castro C; Evora C; Baro M; Soriano I; Sánchez E
    Eur J Pharm Biopharm; 2005 Aug; 60(3):401-6. PubMed ID: 15996581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of intranasal implantable devices for schizophrenia treatment.
    Utomo E; Domínguez-Robles J; Moreno-Castellanos N; Stewart SA; Picco CJ; Anjani QK; Simón JA; Peñuelas I; Donnelly RF; Larrañeta E
    Int J Pharm; 2022 Aug; 624():122061. PubMed ID: 35908633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres.
    Oh JE; Nam YS; Lee KH; Park TG
    J Control Release; 1999 Feb; 57(3):269-80. PubMed ID: 9895414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the biomaterials 3wt%-nanostrontium-hydroxyapatite-enhanced calcium phosphate cement (nanoSr-CPC) and nanoSr-CPC-incorporated simvastatin-loaded poly(lactic-co-glycolic-acid) microspheres in osteogenesis improvement: An explorative multi-phase experimental in vitro/vivo study.
    Masaeli R; Jafarzadeh Kashi TS; Dinarvand R; Rakhshan V; Shahoon H; Hooshmand B; Mashhadi Abbas F; Raz M; Rajabnejad A; Eslami H; Khoshroo K; Tahriri M; Tayebi L
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():171-83. PubMed ID: 27612702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence.
    Nieto K; Pei P; Wang D; Mallery SR; Schwendeman SP
    Int J Pharm; 2018 Mar; 538(1-2):48-56. PubMed ID: 29170116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of monomer order on the hydrolysis of biodegradable poly(lactic-co-glycolic acid) repeating sequence copolymers.
    Li J; Rothstein SN; Little SR; Edenborn HM; Meyer TY
    J Am Chem Soc; 2012 Oct; 134(39):16352-9. PubMed ID: 22950719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
    Wischke C; Zhang Y; Mittal S; Schwendeman SP
    Pharm Res; 2010 Oct; 27(10):2063-74. PubMed ID: 20668921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.